Leerink Partners Raises Price Target on Medtronic (MDT) Following 4Q Report
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
- Wall Street ends lower as solid jobs data fuels hawkish Fed bets
- US nonfarm payrolls blow past expectations in August; unemployment rate steady at 4.1%
- BofA's Hartnett says stay long commodities and gold as 'policy panic' works
- Oil ends week higher on renewed US-Iran strikes, diesel hits record
- TikTok owner ByteDance said to secure $29.6bn loan for AI push
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Wedbush Raises Price Target on Medtronic (MDT) to $82 Following 4Q Report
June 1, 2016 8:41 AM EDTWedbush reiterated a Neutral rating on Medtronic, Inc. (NYSE: MDT), and raised the price target to $82.00 (from $79.00), following the company's 4Q earnings report. MDT reported revenue of $7,567 million, beating the consensus revenue estimate of $7,479 million and was above the upper end of guidance at... More
BTIG Downgrades Medtronic, Inc. (MDT) to Neutral
June 1, 2016 7:18 AM EDTBTIG downgraded Medtronic, Inc. (NYSE: MDT) from Buy to Neutral. Analyst Sean Lavin sees valuation as full and he noted disappointing margins.
"Foremost, at ~$80 we feel valuation is full and no longer see 15% upside over the next 12 months. We also feel... More
Medtronic (MDT): In-Line Quarter, Raising PT - Piper Jaffray
June 1, 2016 6:58 AM EDTPiper Jaffray analyst, Brooks West, raised his PT on Medtronic (NYSE: MDT) to $93 from $85 after the company reported F4Q revenue of $7.57B (+6%cc) vs. consensus of $7.49B. EPS of $1.27, was $0.01 above consensus but the Streets expectation for 300bp of sequential operating leverage... More
Medtronic (MDT) Tops Q4 EPS by 1c
May 31, 2016 6:47 AM EDTMedtronic (NYSE: MDT) reported Q4 EPS of $1.27, $0.01 better than the analyst estimate of $1.26. Revenue for the quarter came in at $7.57 billion versus the consensus estimate of $7.49 billion.
GUIDANCE:
Medtronic sees FY2017 EPS of $4.60-$4.70, versus the consensus of $4.70.
In fiscal... More
